Inoue Y - Search Results

1

Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST study.

Miyazaki Y, Nakayamada S, Tanaka H, Hanami K, Fukuyo S, Kubo S, Miyagawa I, Yamaguchi A, Todoroki Y, Inoue Y, Ueno M, Tanaka Y. Miyazaki Y, et al. Among authors: inoue y. Rheumatology (Oxford). 2024 Jun 18:keae334. doi: 10.1093/rheumatology/keae334. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38889301

2

Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.

Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Inoue Y, Ueno M, Tanaka Y. Miyagawa I, et al. Among authors: inoue y. Int J Rheum Dis. 2019 Mar;22(3):434-442. doi: 10.1111/1756-185X.13387. Epub 2018 Oct 18. Int J Rheum Dis. 2019. PMID: 30338639

3

2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases.

Tanaka Y, Kuwana M, Fujii T, Kameda H, Muro Y, Fujio K, Itoh Y, Yasuoka H, Fukaya S, Ashihara K, Hirano D, Ohmura K, Tabuchi Y, Hasegawa H, Matsumiya R, Shirai Y, Ogura T, Tsuchida Y, Ogawa-Momohara M, Narazaki H, Inoue Y, Miyagawa I, Nakano K, Hirata S, Mori M. Tanaka Y, et al. Among authors: inoue y. Mod Rheumatol. 2021 Jan;31(1):29-33. doi: 10.1080/14397595.2019.1709944. Epub 2020 Jan 7. Mod Rheumatol. 2021. PMID: 31903831 Free article.

4

The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.

Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Kawabe A, Miyazaki Y, Inoue Y, Ueno M, Ohkubo N, Fujita Y, Tanaka Y. Miyagawa I, et al. Among authors: inoue y. Int J Rheum Dis. 2020 Apr;23(4):549-558. doi: 10.1111/1756-185X.13792. Epub 2020 Feb 5. Int J Rheum Dis. 2020. PMID: 32020727

5

Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin-2 Through Transcriptional Regulation in Systemic Lupus Erythematosus.

Hao H, Nakayamada S, Yamagata K, Ohkubo N, Iwata S, Inoue Y, Zhang M, Zhang T, Kanda Satoh Y, Shan Y, Otsuka T, Tanaka Y. Hao H, et al. Among authors: inoue y. Arthritis Rheumatol. 2021 Jan;73(1):132-142. doi: 10.1002/art.41457. Epub 2020 Nov 10. Arthritis Rheumatol. 2021. PMID: 32720470

6

Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis.

Nishida T, Nakano K, Inoue Y, Narumi-Kishimoto Y, Kaname T, Akashi K, Tanaka Y. Nishida T, et al. Among authors: inoue y. Intern Med. 2021 Apr 1;60(7):1109-1114. doi: 10.2169/internalmedicine.5305-20. Epub 2020 Nov 9. Intern Med. 2021. PMID: 33162473 Free PMC article.

7

Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting.

Miyazaki Y, Nakano K, Nakayamada S, Kubo S, Inoue Y, Fujino Y, Tanaka Y. Miyazaki Y, et al. Among authors: inoue y. Ann Rheum Dis. 2021 Sep;80(9):1130-1136. doi: 10.1136/annrheumdis-2020-219699. Epub 2021 Apr 7. Ann Rheum Dis. 2021. PMID: 33827788 Free PMC article.

8

T helper cells expressing fractalkine receptor and bearing T follicular helper 1-like cell functions in patients with IgG4-related disease.

Inoue Y, Nakayamada S, Kubo S, Yamagata K, Sonomoto K, Iwata S, Miyazaki Y, Tanaka Y. Inoue Y, et al. Rheumatology (Oxford). 2022 Aug 30;61(9):3854-3863. doi: 10.1093/rheumatology/keab935. Rheumatology (Oxford). 2022. PMID: 34940835

9

Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus.

Miyazaki Y, Nakayamada S, Sonomoto K, Kawabe A, Inoue Y, Okubo N, Iwata S, Hanami K, Tanaka Y. Miyazaki Y, et al. Among authors: inoue y. Rheumatology (Oxford). 2022 Aug 30;61(9):3614-3626. doi: 10.1093/rheumatology/keab953. Rheumatology (Oxford). 2022. PMID: 34962998 Free PMC article.

10

Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.

Miyagawa I, Nakayamada S, Ueno M, Miyazaki Y, Iwata S, Kubo S, Sonomoto K, Anan J, Ohkubo N, Inoue Y, Tanaka Y. Miyagawa I, et al. Among authors: inoue y. Arthritis Res Ther. 2022 Apr 15;24(1):86. doi: 10.1186/s13075-022-02771-4. Arthritis Res Ther. 2022. PMID: 35428323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,631 results

Search Page

Filters